Omega-3 fatty acids: From biochemistry to their clinical use in the prevention of cardiovascular disease

Recent Patents on Cardiovascular Drug Discovery

Volumn 2, Issue 1, 2007, Pages 13-21

  Colussi, Gian Luca ^a   Catena, Cristiana ^a   Baroselli, Sara ^a   Nadalini, Elisa ^a   Lapenna, Roberta ^a   Chiuch, Alessandra ^a   Sechi, Leonardo A ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

3 polyunsaturated fatty acid; 6 polyunsaturated fatty acids; Arrhythmia; Aspirin; Atherosclerosis; Cardiovascular risk; Coronary heart disease; Docosahexaenoic acid; Eicosapentaenoic acid; Inflammation; Policosanol; Statins

Indexed keywords

ALPHA TOCOPHEROL; ATORVASTATIN; DOCOSAHEXAENOIC ACID; ESAPENT; ESKIM; ICOSANOID; ICOSAPENTAENOIC ACID; MEMBRANE PHOSPHOLIPID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; SIMVASTATIN; UNCLASSIFIED DRUG;

ADD ON THERAPY; ANGIOPLASTY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIET; ENDOCRINE FUNCTION; ESKIMO; ETHNIC GROUP; FATTY ACID TRANSPORT; FISH; FOOD INTAKE; GENE EXPRESSION REGULATION; HEART ARRHYTHMIA; HUMAN; IMMUNE SYSTEM; INGESTION; ISCHEMIC HEART DISEASE; MONOTHERAPY; NERVOUS SYSTEM; PRIORITY JOURNAL; REGULATORY MECHANISM; RESTENOSIS; REVIEW; SIGNAL TRANSDUCTION; SUDDEN DEATH; VISION;

ANIMALS; ARRHYTHMIAS, CARDIAC; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; DIET; FATTY ACIDS, OMEGA-3; HUMANS; HYPERTENSION;

EID: 34249301400     PISSN: 15748901     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489007779606158     Document Type: Review

References (93)

1. Kris-Etherton PM, Taylor DS, Yu-Poth S, et al.: Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 2000; 71: 179S-88.
2. Bang HO, Dyerberg J, Hjoorne T. The composition of food consumed by Greenland Eskimos. Acta Med Scand 1976; 200: 69-73.
3. Bang HO, Dyerberg J, Sinclair HM. The composition of the Eskimo food in north western Greenland. Am J Clin Nutr 1980; 33; 2657-61.
4. Middaugh JP. Cardiovascular deaths among Alaskan Natives, 1980-86. Am J Public Health 1990; 80: 282-85.
5. Newman WP, Middaugh JP, Propst MT, Roger DR. Atherosclerosis in Alaska Natives and non-natives. Lancet 1993; 341: 1056-57.
6. Jump DB. The biochemistry of n-3 polyunsaturated fatty acids. J Biol Chem 2002; 277: 8755-58.
7. Ikonen E. Roles of lipid rafts in membrane transport. Curr Opin Cell Biol 2001; 13: 470-77.
8. Hwang D. Fatty acids and immune responses-a new perspective in searching for clues to mechanisms. Annu Rev Nutr 2000; 20: 431-56.
9. Sellmayer A, Hrboticky N, Weber PC. Lipids in vascular function. Lipids 1999; 34: S13-18.
10. Serhan, C.N., Clish, C.B.: US20067053230 (2006).
11. Clarke SD, Jump DB. Regulation of gene transcription by polyunsaturated fatty acids. Prog Lipid Res 1993; 32: 139-49.
12. Pan DA, Mater MK, Thelen AP, Peters JM, Gonzalez FJ, Jump DB. Evidence against the peroxisome proliferator-activated receptor alpha (PPARα) as the mediator for polyunsaturated fatty acid suppression of hepatic L-pyruvate kinase gene transcription. J Lipid Res 2000; 41: 742-51.
13. Lindeberg S, Lundh B. Apparent absence of stroke and ischaemic heart disease in a traditional Melanesian island: a clinical study in Kitava. J Intern Med 1993; 233: 269-75.
14. Hirai A, Terano T, Tamura Y, Yoshida S. Eicosapentaenoic acid and adult diseases in Japan: epidemiological and clinical aspects. J Intern Med 1989; 225: 69-75.
15. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985; 312: 1205-09.
16. Shekelle RB, Missel LV, Paul O, et al.: Fish consumption and mortality from coronary heart disease. N Engl J Med 1985; 313: 820.
17. Daviglus ML, Stamler J, Orencia AJ, et al.: Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997; 336: 1046-53.
18. Oomen CM, Feskens EJ, Rasanen L, et al. Fish consumption and coronary heart disease mortality in Finland, Italy, and the Netherlands. Am J Epidemiol 2000; 151: 999-1006.
19. Hu FB, Bronner L, Willet WC, et al.: Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002; 287: 1815-21.
20. Mozaffarian D, Lemaitre RN, Kuller LH, et al.: Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation 2003; 107: 1372-77.
21. Curb JD, Reed DM. Fish consumption and mortality from coronary heart disease. N Engl J Med 1985; 313: 821.
22. Vollet Se, Heuch I, Bjelke E. Fish consumption and mortality from coronary heart disease. N Engl J Med 1985; 313: 820-21.
23. Ascherio A, Rimm EB, Stampfer MJ, et al.: Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med 1995; 332: 977-82.
24. Salonen JT, Nyyssonen K, Salonen R. Fish intake and the risk of coronary disease. N Engl J Med 1995; 333: 937.
25. Rodriguez BL, Sharp DS, Abbot RD, et al.: Fish intake may limit the increase in coronary heart disease morbidity and mortality among heavy smokers: the Honolulu Heart Program. Circulation 1996; 94: 952-56.
26. Albert CM, Hennekens CH, O'Donnell CJ, et al.: Fish consumption and risk of sudden cardiac death. JAMA 1998; 279: 23-28.
27. Osler M, Andreasen AH, Hoidrup S. No inverse association between fish consumption and risk of death from all-causes, and incidence of coronary heart disease in middle-aged, Danish adults. J Clin Epidemiol 2003; 56: 274-79.
28. Guallar E, Hennekens CH, Sacks FM, et al.: A prospective study of plasma fish oil levels, and incidence of myocardial infarction in US male physicians. J Am Coll Cardiol 1995; 25: 387-94.
29. Siscovick DS, Raghunathan TE, King I, et al.: Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995; 274: 1363-67.
30. Burr ML, Fehily AM, Gilbert JF, et al.: Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989; ii: 757-61.
31. de Lorgeril M, Renaud S, Mamelle N, et al.: Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994; 343: 1454-59.
32. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999; 99: 779-85.
33. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto miocardico. Lancet 1999; 3554: 447-55.
34. Albert CM, Campos H, Stampfer MJ, et al.: Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002; 346: 1113-18.
35. Guallar A, Aro A, Jimenez FJ, Martin-Moreno JM, et al.: Omega-3 fatty acids in adipose tissue and risk of myocardial infarction: the EURAMIC study. Arterioscler Thromb Vasc Biol 1999; 19: 1111-18.
36. He K, Song Y, Daviglus ML, et al.: Accumulated evidence of fish oil consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 2004; 109: 2705-11.
37. Konig A, Bouzan C, Cohen JT, et al.: A quantitative analysis of fish consumption and coronary heart disease mortality. Am J Prev Med 2005; 29: 335-46.
38. Harper CR, Jacobson TA. Usefulness of omega-3 fatty acids and the prevention of coronary heart disease. Am J Cardiol 2005; 96: 1521-29.
39. Bucher HC, Hengstler P, Schindler C, et al.: N-3 polyunstaurated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002; 112: 298-304.
40. Whelton SP, He J, Whelton PK, et al.: Meta-analysis of observational studies on fish intake and coronary heart disease. Am J Cardiol 2004; 93: 1119-23.
41. Yzebe D and Lievre M. Fish oils in the care of coronary heart disease patients: a meta-analysis of randomized controlled trials. Fundam Clin Pharmacol 2004; 18: 581-92.
42. Hooper L, Thompson RL, Harrison RA, et al.: Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev 2004; 4: CD003177.
43. Covington MB. Omega-3 fatty acids. Am Fam Physician 2004; 70: 133-40.
44. Howe PR. Dietary fats and hypertension. Focus on fish oil. Ann N Y Acad Sci 1997; 827: 339-52.
45. Bonaa KH, Bjerve KS, Straume B, et al.: Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromso study. N Engl J Med 1990; 322: 795-801.
46. Prisco D, Paniccia R, Bandinelli B, et al.: Effect of medium-term supplementation with a moderate dose of n-3 polyunsaturated fatty acids on blood pressure in mild hypertensive patients. Thromb Res 1998; 91: 105-12.
47. Knapp HR, and FitzGerald GA. The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supplements in essential hypertension. N Engl J Med 1989; 320: 1037-43.
48. Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993; 88: 523-33.
49. Harris WS, Ginsberg HN, Arunakul N, et al.: Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk 1997; 4: 385-91.
50. Harris WS. N-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997; 65: 1645-54.
51. Cavazza, C.: WO06013602A1 (2006).
52. Hong H, Xu ZM, Pang BS, et al.: Effects of simvastain combined with omega-3 fatty acids on high sensitive C-reactive protein, lipidemia, and fibrinolysis in patients with mixed dyslipidemia. Chin Med Sci J 2004; 19: 145-49.
53. Nordoy A, Hansen JB, Brox J, et al.: Effects of atorvastatin and omega-3 fatty acids on LDL subfractions and postprandial hyperlipemia in patients with combined hyperlipemia. Nutr Metab Cardiovasc Dis 2001; 11: 7-16.
54. Nordoy A, Bonaa KH, Sandset PM, et al. Effect of omega-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia. Arterioscler Thromb Vasc Biol 2000; 20: 259-65.
55. Catena C, Novello M, Lapenna R, et al. New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a). J Hypertens 2005; 23: 1617-31.
56. Colussi GL, Baroselli S, Sechi LA. ω-3 polyunsaturated fatty acids decrease plasma lipoprotein(a) levels in hypertensive subjects. Clin Nutr 2004; 23: 1246-47.
57. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14-22.
58. Yamada T, Malcom GT, Strong JP; et al. Difference in atherosclerosis between the populations of a fishing and a farming village in Japan. Ann NY Acad Sci 1997; 811: 412-19.
59. Djoussé L, Folsom AR, Province MA, Hunt SC, Ellison RC. Dietary linolenic acid and carotid atherosclerosis : the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr 2003; 77: 819-25.
60. Angerer P, Kothny W, Stork S, von Schacky C. Effect of dietary supplementation with omega-3 fatty acids on progression of atherosclerosis in carotid arteries. Cardiovasc Res 2002; 54: 183-90.
61. De Caterina R, Madonna R, Massaro M. Effects of omega-3 fatty acids on cytokines and adhesion molecules. Curr Atheroscler Rep 2004; 6: 485-91.
62. Miles EA, Thies F, Wallace FA, et al. Influence of age and dietary fish oil on plasmas soluble adhesion molecule concentrations. Clin Sci 2001; 100: 91-100.
63. Baumann KH, Hessel F, Larass I, et al. Dietary ω-3, ω-6, and ω-9 unsaturated fatty acids and growth factor and cytokine gene expression in unstimulated and stimulated monocytes. Arterioscler Thromb Vasc Biol 1999; 19: 59-66.
64. Sperling RI, Benincaso AI, Knoell CT, Larkin JK, Austen KF, Robinson DR. Dietary ω-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest 1993; 91: 651-60.
65. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-74.
66. Massaro M, Basta G, Lazzerini G, et al. Quenching of intracellular ROS generation as a mechanism for oleate-induced reduction of endothelial activation and early atherogenesis. Thromb Haemost 2002; 88: 335-44.
67. De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA Jr, Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 1994; 14: 1829-36.
68. De Caterina R, Bernini W, Carluccio MA, Liao JK, Libby P. Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids. J Lipid Res 1998; 39: 1062-70.
69. Marchioli R, Schweiger C, Tavazzi L, Valagussa F. Effect of ω-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto del Miocardio. Lipids 2001; 36: S119-S26.
70. Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, Moshiri M. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival-4. Cardiovasc; Drugs Ther 1997; 11: 485-91.
71. Singh RB, Dubnov G, Niaz MA, et al. Effect of Indo-Mediterranean diet on progression of coronary artery disease in high-risk patients (Indo-Mediterranean Diet Heart Study): a randomized single-blind trial. Lancet 2002; 360: 1455-61.
72. Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden cardiac death by n-3 polyunsaturated fatty acids after myocardial infarction. Circulation 2002; 105: 1897-903.
73. Matthan NR, Jordan H, Chung M, Lichtenstein AH, Lathrop DA, Lau J. A systematic review meta-analysis of the impact of ω-3 fatty acids on selected arrhythmia outcomes in animal models. Metabolism 2005; 54: 1557-65.
74. Raitt M, Conner W, Morris C, et al. Antiarrhythmic effects of n-3 polyunsaturated fatty acids in survivors of ventricular tachyarrhythmias. Circulation 2003; 108: 2723.
75. Maggioni AP, Tavazzi L, Marchioli R, Tognoni G, Avanzini F, Roncaglioni MG. Perspectives on n-3 PUFAs: primary prevention, antiarrhythmic effects, congestive heat failure. Eur Heart J 2002; 3: D106-09.
76. Brower IA, Zock PL, Wever EFD, et al. Rationale and design of randomized controlled clinical trial on supplemental intake of n-3 fatty acids and incidence of cardiac arrhythmia: SOFA. Eur J Clin Nutr 2003; 57: 1323-30.
77. Schrepf R, Limmert T, Weber PC, Theisen K, Sellmayer A. Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia. Lancet 2004; 363: 1441-42.
78. Calò L, Bianconi L, Colivicchi F, et al. N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 2005; 45: 1723-28.
79. McLennan PL, Abeywardena MY, Charnock JS. Dietary fish oil prevents ventricular fibrillation following coronary artery occlusion and reperfusion. Am Heart J 1988; 116: 709-17.
80. Leaf A, Jorgensen MB, Jacobs AK, et al. Do fish oil prevent restenosis after coronary angioplasty? Circulation 1994; 90: 2248-57.
81. Grimminger F, Grimm H, Fuhrer D, et al. Omega-3 lipid infusion in a heart allotransplant model: shift in fatty acid and lipid mediator profiles and prolongation of transplant survival. Circulation 1996; 93: 365-71.
82. Kang JX, Leaf A. Effects of long-chain poyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes. Proc Natl Acad Sci USA 1994; 91: 9886-90.
83. McLennan PL. Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models. Lipids 2001; 36: S111-14.
84. Leifert WR, Jahangiri A, McMurchie EJ. Membrane fluidity changes are associated with antiarrhythmic effects of docosa-hexaenoic acid in adult rat cardiomyocytes. J Nutr Biochem 2000; 11: 38-44.
85. Grynberg A, Fournier A, Sergiel JP, Athias P. Membrane docosahexaenoic acid vs. eicosapentaenoic acid and the beating function of the cardiomyocyte and its regulation through the adrenergic receptors. Lipids 1996; 31: 205-10.
86. Dai J, Williams SA, Zeighelhoffer A. Structure-activity relationship of the effect of dietary supplementation of fish oil on experimental myocardial infarction. Circ Res 1995; 52: 167-71.
87. Charnock JS. Omega-3 polyunsaturated fatty acids and ventricular fibrillation: the possible involvement of eicosanoids. Prostaglandins Leukot Essent Fatty Acids 1999; 61: 243-47.
88. + channels of neonatal rat ventricular myocytes. Proc Natl Acad Sci USA 1995; 92: 11000-11004.
89. 2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci USA 1997; 94: 4182-87.
90. Berlin, R.: US20060020031A1 (2006).
91. Berlin, R.: WO06014790A2 (2006).
92. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. American Heart Association Nutrition Committee. Circulation 2002; 106: 2747-57.
93. Van de Werf F, Ardissino D, Betriu. A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2003; 24: 26-66.